![David Berk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Berk
Chief Tech/Sci/R&D Officer at
ARCUTIS BIOTHERAPEUTICS, INC.
Profile
Dr. David Berk, MD, is a Vice President-R&D Strategy, Clinical Development at Arcutis Biotherapeutics, Inc. Dr. Berk was previously employed as an Executive Director & Head-Medical Dermatology by Allergan, Inc. and an Assistant Professor by Washington University in St. Louis.
He received his undergraduate degree from Princeton University and a doctorate degree from Stanford University.
David Berk active positions
| Companies | Position | Start |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2018-12-31 |
Former positions of David Berk
| Companies | Position | End |
|---|---|---|
| ALLERGAN, INC. | Director/Board Member | 2018-11-30 |
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2011-12-31 |
Training of David Berk
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
75
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Washington University in St. Louis
Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcutis Biotherapeutics, Inc.
 Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
- Stock Market
- Insiders
- David Berk
